Pfizer Ltd. Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Mar'24

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Sep 2025 is 6.52% vs 1.88% in Jun 2025

Standalone Net Profit

QoQ Growth in quarter ended Sep 2025 is -1.42% vs -42.06% in Jun 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is 9.48% vs -7.68% in Jun 2025

Interest

QoQ Growth in quarter ended Sep 2025 is -34.46% vs 20.82% in Jun 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

Compare Quarterly Results Of Pfizer With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

642.34

380.00

262.34

69.04%

Other Operating Income

0.00

Total Operating income

642.34

380.00

262.34

69.04%

Raw Material Cost

70.00

75.00

-5.00

-6.67%

Purchase of Finished goods

221.27

51.00

170.27

333.86%

(Increase) / Decrease In Stocks

-63.32

-55.00

-8.32

-15.13%

Employee Cost

94.67

88.00

6.67

7.58%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

89.79

108.00

-18.21

-16.86%

Total Expenditure (Excl Depreciation)

412.41

267.00

145.41

54.46%

Operating Profit (PBDIT) excl Other Income

229.93

113.00

116.93

103.48%

Other Income

41.85

30.00

11.85

39.50%

Operating Profit (PBDIT)

271.78

143.00

128.78

90.06%

Interest

2.13

44.00

-41.87

-95.16%

Exceptional Items

0.00

Gross Profit (PBDT)

269.65

99.00

170.65

172.37%

Depreciation

14.28

45.00

-30.72

-68.27%

Profit Before Tax

255.37

54.00

201.37

372.91%

Tax

66.35

0.00

66.35

Provisions and contingencies

0.00

Profit After Tax

189.02

54.00

135.02

250.04%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

189.02

54.00

135.02

250.04%

Equity Capital

45.75

81.00

-35.25

-43.52%

Face Value

10.00

5.00

0.00

Reserves

0.00

Earnings per share (EPS)

41.32

3.33

37.99

1,140.84%

Diluted Earnings per share

41.32

3.25

38.07

1,171.38%

Operating Profit Margin (Excl OI)

35.80%

29.74%

0.00

6.06%

Gross Profit Margin

41.98%

26.05%

0.00

15.93%

PAT Margin

29.43%

14.21%

0.00

15.22%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 642.34 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 6.52% vs 1.88% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 9.13% vs 2.33% in Sep 2024

Quarterly - Standalone Net Profit

Standalone Net Profit 189.02 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is -1.42% vs -42.06% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 19.37% vs 6.30% in Sep 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 229.93 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 9.48% vs -7.68% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 21.50% vs 3.64% in Sep 2024

Quarterly - Interest

Interest 2.13 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is -34.46% vs 20.82% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 1.43% vs -23.08% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 35.80%

in Sep 2025

Figures in %

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024